Modulation de l'immunosuppression par des chimiothérapies et identification de nouvelles cibles thérapeutiques = Impact of chemotherapies on immunosuppression and discovery of new therapeutic targetsBRUCHARD, Mélanie; GHIRINGHELLI, François.Bulletin du cancer. 2014, Vol 101, Num 6, pp 605-607, issn 0007-4551, 3 p.Article

Stratégies vaccinales contre le mélanome = Melanoma immunotherapyGHIRINGHELLI, Francois; ZITVOGEL, Laurence.MS. Médecine sciences. 2006, Vol 22, Num 2, pp 183-187, issn 0767-0974, 5 p.Article

Retrospective analysis of survival benefits of chemotherapy for metastatic or non-resectable intrahepatic cholangiocarcinomaWIAZZANE, Nadia; CHAUFFERT, Bruno; GHIRINGHELLI, François et al.Clinics and research in hepatology and gastroenterology (Print). 2013, Vol 37, Num 6, pp 614-618, issn 2210-7401, 5 p.Article

Influcence of Localization of Primary Tumor on Effectiveness of 5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) in Patients with Metastatic Pancreatic Adenocarcinoma: A Retrospective StudyLORGIS, Veronique; CHAUFFERT, Bruno; GENTIL, Julie et al.Anticancer research. 2012, Vol 32, Num 9, pp 4125-4130, issn 0250-7005, 6 p.Article

Cellules myéloïdes suppressives et cancer: une nouvelle cible thérapeutique = Myeloid-derived suppressor cells: a key player in cancerCHALMIN, Fanny; MIGNOT, Grégoire; GHIRINGHELLI, François et al.MS. Médecine sciences. 2010, Vol 26, Num 6-7, pp 576-579, issn 0767-0974, 4 p.Article

Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancerLADOIRE, Sylvain; MARTIN, François; GHIRINGHELLI, François et al.Cancer immunology and immunotherapy. 2011, Vol 60, Num 7, pp 909-918, issn 0340-7004, 10 p.Article

Metronomic Cyclophosphamide with Cisplatin and Bevacizumab: A New Chemotherapeutic Regimen for Refractory Anaplastic EpendymomaLORGIS, Veronique; VARBEDIAN, Olivier; GHIRINGHELLI, Francois et al.Anticancer research. 2012, Vol 32, Num 11, pp 5067-5070, issn 0250-7005, 4 p.Article

La calréticuline détermine l'immunogénicité de la chimiothérapie et de la radiothérapie antitumorales = Calreticulin exposure dictates the immunogenicity of cancer cell deathAPETOH, Lionel; GHIRINGHELLI, Francois; ZITVOGEL, Laurence et al.MS. Médecine sciences. 2007, Vol 23, Num 3, pp 257-258, issn 0767-0974, 2 p.Article

Hepatic Arterial Infusion of Gemcitabine plus Oxaliplatin as Second-Line Treatment for Locally Advanced Intrahepatic Cholangiocarcinoma: Preliminary ExperienceGHIRINGHELLI, François; LORGIS, Veronique; VINCENT, Julie et al.Chemotherapy (Basel). 2013, Vol 59, Num 5, pp 354-360, issn 0009-3157, 7 p.Article

Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma modelBANISSI, Claire; GHIRINGHELLI, François; LIN CHEN et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 10, pp 1627-1634, issn 0340-7004, 8 p.Article

Cancer chemotherapy : not only a direct cytotoxic effect, but also an adjuvant for antitumor immunityMENARD, Cédric; MARTIN, Francois; APETOH, Lionel et al.Cancer immunology and immunotherapy. 2008, Vol 57, Num 11, pp 1579-1587, issn 0340-7004, 9 p.Article

In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survivalLADOIRE, Sylvain; MIGNOT, Grégoire; COUTANT, Charles et al.Journal of pathology (Print). 2011, Vol 224, Num 3, pp 389-400, issn 0022-3417, 12 p.Article

Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer ImmunityAYMERIC, Laetitia; APETOH, Lionel; GHIRINGHELLI, François et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 3, pp 855-858, issn 0008-5472, 4 p.Article

Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: A pooled analysis of two randomised trialsLADOIRE, Sylvain; DALBAN, Cecile; ROCHE, Henri et al.European journal of cancer (1990). 2014, Vol 50, Num 3, pp 506-516, issn 0959-8049, 11 p.Article

Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in MiceMICHAUD, Mickaël; MARTINS, Isabelle; RELLO-VARONA, Santiago et al.Science (Washington, D.C.). 2011, Vol 334, Num 6062, pp 1573-1577, issn 0036-8075, 5 p.Article

Natural Killer Cell IFN-γ Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor-Bearing PatientsMENARD, Cédric; BLAY, Jean-Yves; FLAMENT, Caroline et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 8, pp 3563-3569, issn 0008-5472, 7 p.Article

Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell deathAIRES, Virginie; LIMAGNE, Emeric; COTTE, Alexia K et al.Molecular nutrition & food research (Print). 2013, Vol 57, Num 7, pp 1170-1181, issn 1613-4125, 12 p.Article

An Immunosurveillance Mechanism Controls Cancer Cell PloidySENOVILLA, Laura; VITALE, Ilio; SHEN, Shensi et al.Science (Washington, D.C.). 2012, Vol 337, Num 6102, pp 1678-1684, issn 0036-8075, 7 p.Article

Cancer-Induced Immunosuppression: IL-18-Elicited Immunoablative NK CellsTERME, Magalj; ULIRICHL, Evelyn; LIEPING CHEN et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 11, pp 2757-2767, issn 0008-5472, 11 p.Article

SOCS3 Transactivation by PPARγ Prevents IL-17-Driven Cancer GrowthBERGER, Hélène; VEGRAN, Frédérique; CHEVRIAUX, Angélique et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 12, pp 3578-3590, issn 0008-5472, 13 p.Article

Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancerGUIU, Boris; PETIT, Jean Michel; GHIRINGHELLI, François et al.Gut. 2010, Vol 59, Num 3, pp 341-347, issn 0017-5749, 7 p.Article

Intérêt du génotypage de l'UGT1A1 dans le cadre du traitement des cancers digestifs par irinotécan = Interest of UGT1A1 genotyping within digestive cancers treatment by irinotecanBOYER, Jean-Christophe; ETIENNE-GRIMALDI, Marie-Christine; LE MORVAN, Valérie et al.Bulletin du cancer. 2014, Vol 101, Num 6, pp 533-553, issn 0007-4551, 21 p.Article

Sodium citrate versus saline catheter locks for non-tunneled hemodialysis central venous catheters in critically ill adults: a randomized controlled trialHERMITE, Laure; QUENOT, Jean-Pierre; NADJI, Abdelouaid et al.Intensive care medicine (Print). 2012, Vol 38, Num 2, pp 279-285, issn 0342-4642, 7 p.Article

Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapyLADOIRE, Sylvain; ARNOULD, Laurent; FUMOLEAU, Pierre et al.Breast cancer research and treatment. 2011, Vol 125, Num 1, pp 65-72, issn 0167-6806, 8 p.Article

Metronomic Oral Cyclophosphamide Prednisolone Chemotherapy Is an Effective Treatment for Metastatic Hormone-refractory Prostate Cancer after Docetaxel FailureLADOIRE, Sylvain; EYMARD, Jean Christophe; ZANETTA, Sylvie et al.Anticancer research. 2010, Vol 30, Num 10, pp 4317-4323, issn 0250-7005, 7 p.Article